A preferred formulation may drive
patient compliance.2

  • EXTINA® Foam is the only antifungal agent formulated in VersaFoam-HF™, a novel hydroethanolic foam vehicle1

Why does vehicle matter?
Because patients prefer foam.2,3

  • EXTINA® Foam can be used when the skin and hair are wet or dry,1 making it an excellent treatment option regardless of gender and lifestyle
  • Ease of application may increase the likelihood of patient compliance2,3

Important safety information

EXTINA® (ketoconazole) Foam, 2% is indicated for the topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older. Safety and efficacy of EXTINA® Foam for treatment of fungal infections have not been established.

The most common adverse reactions to EXTINA® Foam observed in clinical trials
(incidence >1%) were application site burning (10%) and application site reaction (6%).

EXTINA® Foam may result in contact sensitization, including photoallergenicity.

EXTINA® Foam is not for ophthalmic, oral, or intravaginal use.

Full Prescribing Information for EXTINA® Foam

Extina<sup>®</sup> - The difference is in the delivery

Download the patient brochure Prescribing Info